FDA & Regulatory
Recalls, PMA approvals, and adverse events for heart valve devices
Event Type
Company
All CompaniesABBOTT MEDICALATS Medical, Inc.Abbott MedicalBoston Scientific CorporationCardinal HealthCardinal Health 200, LLCCorcym S.r.l.Cryolife IncEdwards Lifesciences, LLCLifeNetMedline Industries, LPMedtronic, Inc.Occlutech Holding AGOn-X Life Technologies, Inc.W. L. Gore & Associates, Inc.
Clear filters6 events
PMA ApprovalJun 22, 2026
FDA PMA: Epic Elite Mitral; Epic Elite Aortic; Epic Supra G3 valvesCompany: ABBOTT MEDICAL
— Applicant: ABBOTT MEDICAL
PMA ApprovalJun 11, 2026
FDA PMA: Masters Series Aortic Valved Graft with Hemashield Graft Technology (CAVGJ)Company: ABBOTT MEDICAL
— Applicant: ABBOTT MEDICAL
PMA ApprovalMay 28, 2026
FDA PMA: AmplatzerTM PFO Occluder; AmplatzerTM Talisman PFO OccluderCompany: ABBOTT MEDICAL
— Applicant: ABBOTT MEDICAL
PMA ApprovalMay 28, 2026
FDA PMA: AmplatzerTM Septal Occluder; AmplatzerTM Multifenestrated Septal Occluder - CribriformCompany: ABBOTT MEDICAL
— Applicant: ABBOTT MEDICAL
PMA ApprovalMay 28, 2026
FDA PMA: AmplatzerTM Muscular VSD OccluderCompany: ABBOTT MEDICAL
— Applicant: ABBOTT MEDICAL
RecallMay 25, 2026
Recall: Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, 35 mm, NVRO-35, SterileCompany: Abbott Medical
A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impact...